Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus

AIDS

Volumn 20, Issue 6, 2006, Pages 871-877

  Saadoun, David ^a   Aaron, Laurent ^b   Resche Rigon, Mathieu ^c   Pialoux, Gilles ^d   Piette, Jean Charles ^a   Cacoub, Patrice ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hôpital de Bourges   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL TENON   (France)

Author keywords

Hepatitis C virus; HIV; Mixed cryoglobulinaemia; Vasculitis

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; RIBAVIRIN;

ADULT; AGE; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DEATH; FEMALE; FOLLOW UP; GENDER; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; KIDNEY DISEASE; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYNEUROPATHY; PRIORITY JOURNAL; PURPURA; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VASCULITIS; VIREMIA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CRYOGLOBULINEMIA; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TREATMENT OUTCOME; VASCULITIS; VIRAL LOAD;

EID: 33646700542     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000218551.62210.b5     Document Type: Article

References (24)

1. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69:287-308.
2. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-1495.
3. Bonnet F, Pineau JJ, Taupin JL, Feyler A, Bonarek M, de Witte S, et al. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. J Rheumatol 2003; 30:2005-2010.
4. Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999; 130:226-230.
5. Stricker RB, Sanders KA, Owen WF, Kiprov DD, Miller RG. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology 1992; 42:2103-2105.
6. Castillo JR, Kirchner E, Farver C, Calabrese LH. Cryoglobulinemic vasculitis and lymphocytic interstitial pneumonitis in a person with HIV infection. AIDS Read 2005; 15:252-255.
7. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000; 30 (Suppl 1):S77-S84.
8. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine 2000; 79: 47-56.
9. Cohen P, Roulot D, Ferriere F, Nguyen QT, Lortholary O, Jarrousse B, et al. Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. Clin Exp Rheumatol 1997; 15:523-527.
10. Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, et al. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. Clin Virol 2004; 31:210-214.
11. Monsuez JJ, Vittecoq D, Musset L, Alemanni M, Dussaix E, Autran B. Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus. Arthritis Rheum 1998; 41:740-743.
12. Antinori S, Galimberti L, Rusconi S, Zehender G, Esposito R, Galli M. Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 1995; 13 (Suppl 13):S157-S159.
13. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20.
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2004. http://www.R-project.org
15. Calabrese LH. Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 2004; 22:S87-S93.
16. Gherardi R, Belec L, Mhiri C, Gray F, Lescs MC, Sobel A, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 1993; 36:1164-1174.
17. Le Lostec Z, Fegueux S, Vitale C, Geoffroy O, Bleton F, Mornet P. Peripheral neuropathy associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-infected patient. AIDS 1994; 8:1351-1352.
18. Gisselbrecht M, Cohen P, Lortholary O, Jarrousse B, Gayraud M, Lecompte I, et al. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Med Intern 1998; 149:398-405.
19. Mackay F, Ambrose C. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol 2003; 170:5965-5972.
20. Aaron L, Lebray P, Alyanakian MA, Roudiere L, Therby A, Chaix ML, et al. Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2005; 40:306-308.
21. Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004; 103:3428-3430.
22. Bonetti B, Invernizzi F, Rizzuto N, Bonazzi ML, Zanusso GL, Chinaglia G, et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol 1997; 73:145-154.
23. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghiliani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 46:3317-3326.
24. Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005; 52:911-915.